During the past decade, Instituto de Investigaciones Clínicas - Rosario conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 11 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Investigaciones Clínicas - Rosario" #1 sponsor was "Allergan" with 4 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Investigaciones Clínicas - Rosario" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator and "Amarin Pharma Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Investigaciones Clínicas - Rosario" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Heart Failure" (2 trials) and "Hypertension" (2 trials). Many other conditions were trialed in "Instituto de Investigaciones Clínicas - Rosario" in a lesser frequency.

Most popular intervention types in "Instituto de Investigaciones Clínicas - Rosario" are "Drug" (16 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Relamorelin" (3 trials), "Darusentan" (2 trials), "Empagliflozin" (2 trials) and "Guanfacine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Investigaciones Clínicas - Rosario" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto de Investigaciones Clínicas - Rosario". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Instituto de Investigaciones Clínicas - Rosario, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Investigaciones Clínicas - Rosario, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".